CG
ARNA

Cutler Group’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Cutler Group’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-32,200
Closed -$19K – 6437
2021
Q4 		$19K Buy
+32,200
New +$2.12M ﹤0.01% 3192
2020
Q3 		– Sell
-4,500
Closed -$4K – 5448
2020
Q2 		$4K Buy
+4,500
New +$248K ﹤0.01% 3534
2020
Q1 		– Sell
-4,200
Closed -$3K – 4916
2019
Q4 		$3K Buy
4,200
+1,000
+31% +$47.3K ﹤0.01% 3368
2019
Q3 		$12K Sell
3,200
-2,000
-38% -$112K ﹤0.01% 2550
2019
Q2 		$12K Buy
+5,200
New +$269K ﹤0.01% 2581
2019
Q1 		– Sell
-1,200
Closed -$1K – 5008
2018
Q4 		$1K Sell
1,200
-6,000
-83% -$236K ﹤0.01% 3788
2018
Q3 		$4K Buy
7,200
+3,000
+71% +$122K ﹤0.01% 3245
2018
Q2 		$12K Sell
4,200
-8,300
-66% -$357K ﹤0.01% 2566
2018
Q1 		$44K Buy
12,500
+5,200
+71% +$202K ﹤0.01% 1753
2017
Q4 		$1K Buy
7,300
+2,500
+52% +$71.2K ﹤0.01% 4677
2017
Q3 		$4K Buy
4,800
+2,300
+92% +$52.8K ﹤0.01% 4677
2017
Q2 		$1K Buy
+2,500
New +$34.3K ﹤0.01% 6125

Cutler Group's ARNA Position: Q1 2022 in Review

Cutler Group sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 40,913 shares — an estimated $3.8M sold.

Cutler Group first reported a position in ARNA in Q2 2017 and held it in 15 quarters. The position peaked at $3.8M in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

  • Cutler Group reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
  • Cutler Group sold 40,913 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $3.8M.
  • Cutler Group first reported a position in Arena Pharmaceuticals Inc in Q2 2017 and held it in 15 quarters.
  • Cutler Group's Arena Pharmaceuticals Inc position peaked at $3.8M in Q4 2021.
  • 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Cutler Group's 13F filing for Q1 2022, filed 14 Apr 2022.